cefixime has been researched along with Infections, Staphylococcal in 5 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, open clinical study, 50 urological patients with acute pyelonephritis were treated with the oral cephalosporin cefixime." | 9.06 | [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis]. ( Segal, A; Tröster, K; Weissbach, L, 1990) |
| "In a prospective, open clinical study, 50 urological patients with acute pyelonephritis were treated with the oral cephalosporin cefixime." | 5.06 | [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis]. ( Segal, A; Tröster, K; Weissbach, L, 1990) |
| "Cefixime is a third-generation cephalosporin and is widely used in clinical practice in childhood." | 1.38 | Cefixime-induced oculogyric crisis. ( Bayram, E; Bayram, MT; Hiz, S; Turkmen, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayram, E | 1 |
| Bayram, MT | 1 |
| Hiz, S | 1 |
| Turkmen, M | 1 |
| Savini, V | 1 |
| Crescenzi, C | 1 |
| Astolfi, D | 1 |
| Marrollo, R | 1 |
| Balbinot, A | 1 |
| D'Amario, C | 1 |
| Carretto, E | 1 |
| Fazii, P | 1 |
| D'Antonio, D | 1 |
| Hamilton-Miller, JM | 1 |
| Weissbach, L | 1 |
| Segal, A | 1 |
| Tröster, K | 1 |
| Matsui, H | 1 |
| Hiraoka, M | 1 |
| Inoue, M | 1 |
| Mitsuhashi, S | 1 |
1 review available for cefixime and Infections, Staphylococcal
| Article | Year |
|---|---|
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemop | 2000 |
1 trial available for cefixime and Infections, Staphylococcal
| Article | Year |
|---|---|
[Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Body Temperature; Cef | 1990 |
3 other studies available for cefixime and Infections, Staphylococcal
| Article | Year |
|---|---|
Cefixime-induced oculogyric crisis.
Topics: Anti-Bacterial Agents; Attention Deficit Disorder with Hyperactivity; Cefixime; Child; Dopamine Anta | 2012 |
VITEK 2 may deduce false susceptibility to cefixime in Staphylococcus.
Topics: Anti-Bacterial Agents; Cefixime; False Positive Reactions; Humans; Microbial Sensitivity Tests; Stap | 2012 |
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; G | 1990 |